Tags

Type your tag names separated by a space and hit enter

Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder.
Chang Gung Med J. 2010 Mar-Apr; 33(2):211-5.CG

Abstract

Aripiprazole, an atypical antipsychotic, is effective in children with psychosis and few adverse effects have been reported. However, little is known about the efficacy and safety of aripiprazole in the treatment of autistic or other pervasive developmental disorders. We report three children with pervasive developmental disorders who were treated with aripiprazole for associated behavioral syndromes. Aripiprazole significantly improved the social interaction of all three children. Furthermore, two patients also showed significant improvement in depression/anxiety syndromes. The outcomes achieved with aripiprazole in these cases suggest that it is a potential therapeutic agent for children with pervasive developmental disorders.

Authors+Show Affiliations

Department of Psychiatry, Chung-Shan Medical University Hospital, Taichung, Taiwan.No affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

20438675

Citation

Huang, Shu-Chi, et al. "Aripiprazole Improves Social Interaction in Taiwanese Children With Pervasive Developmental Disorder." Chang Gung Medical Journal, vol. 33, no. 2, 2010, pp. 211-5.
Huang SC, Tsai SJ, Yang HJ. Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder. Chang Gung Med J. 2010;33(2):211-5.
Huang, S. C., Tsai, S. J., & Yang, H. J. (2010). Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder. Chang Gung Medical Journal, 33(2), 211-5.
Huang SC, Tsai SJ, Yang HJ. Aripiprazole Improves Social Interaction in Taiwanese Children With Pervasive Developmental Disorder. Chang Gung Med J. 2010 Mar-Apr;33(2):211-5. PubMed PMID: 20438675.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder. AU - Huang,Shu-Chi, AU - Tsai,Shih-Jen, AU - Yang,Hao-Jan, PY - 2010/5/5/entrez PY - 2010/5/5/pubmed PY - 2010/8/7/medline SP - 211 EP - 5 JF - Chang Gung medical journal JO - Chang Gung Med J VL - 33 IS - 2 N2 - Aripiprazole, an atypical antipsychotic, is effective in children with psychosis and few adverse effects have been reported. However, little is known about the efficacy and safety of aripiprazole in the treatment of autistic or other pervasive developmental disorders. We report three children with pervasive developmental disorders who were treated with aripiprazole for associated behavioral syndromes. Aripiprazole significantly improved the social interaction of all three children. Furthermore, two patients also showed significant improvement in depression/anxiety syndromes. The outcomes achieved with aripiprazole in these cases suggest that it is a potential therapeutic agent for children with pervasive developmental disorders. SN - 2309-835X UR - https://www.unboundmedicine.com/medline/citation/20438675/Aripiprazole_improves_social_interaction_in_Taiwanese_children_with_pervasive_developmental_disorder_ L2 - http://cgmj.cgu.edu.tw/3302/330213.pdf DB - PRIME DP - Unbound Medicine ER -